Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Twist Bioscience Corporation (TWST) Tops Q2 EPS by 8c, Offers Guidance
May 5, 2023 7:39 AM EDTTwist Bioscience Corporation (NASDAQ: TWST) reported Q2 EPS of ($1.04), $0.08 better than the analyst estimate of ($1.12). Revenue for the quarter came in at $60.2 million versus the consensus estimate of $56.64 million.
GUIDANCE:
Twist Bioscience Corporation sees Q3 2023 revenue of $60-61... More
